首页> 外文学位 >Mechanism of DNA damage, cell cycle arrest and apoptosis in indolent B-cell lymphomas.
【24h】

Mechanism of DNA damage, cell cycle arrest and apoptosis in indolent B-cell lymphomas.

机译:惰性B细胞淋巴瘤的DNA损伤,细胞周期停滞和凋亡机制。

获取原文
获取原文并翻译 | 示例

摘要

The disease course of mature B cell lymphoma such as plasma cell and lymphoplasmatic neoplasms are generally indolent, mimicking the low-grade (LG) non-hodgkin's lymphomas. Such LGL and indolent tumors include the chronic lymphocytic leukemia (CLL), Hairy-cell leukemia (HCL), Waldenstrom's macroglobulinemia (WM), and Multiple myeloma (MM). Based on disease progression, response to chemotherapy, and relapse events, LGL and indolent tumors are presently considered unfavorable and incurable with current treatment protocols. The major concern in the treatment of patients with indolent lymphoid malignancies is the problem of relapse (resistant residual cells). Combinations of chemotherapeutic agents have not been successful in irradiating refractory cells. Understanding the mechanism of anti-tumor activity of chemo-therapeutic agents in indolent B-lymphomas, and the responses of these tumors, may explain how residual cells resist the effect of certain chemotherapy drugs. We may then be able to understand the transition indolent cells go through in order to survive, and then target our treatment directly and more effectively.
机译:成熟的B细胞淋巴瘤(如浆细胞和淋巴质性肿瘤)的病程通常是缓慢的,类似于低级(LG)非霍奇金淋巴瘤。此类LGL和惰性肿瘤包括慢性淋巴细胞性白血病(CLL),毛细胞白血病(HCL),华氏巨球蛋白血症(WM)和多发性骨髓瘤(MM)。基于疾病的进展,对化学疗法的反应以及复发事件,目前认为LGL和顽固性肿瘤不利于当前的治疗方案并且无法治愈。惰性淋巴样恶性肿瘤患者治疗的主要问题是复发(耐药性残留细胞)问题。化学疗法的组合在辐射难治性细胞方面尚未成功。了解惰性B淋巴瘤中化学治疗剂的抗肿瘤活性机制以及这些肿瘤的反应,可能可以解释残留细胞如何抵抗某些化学疗法药物的作用。然后,我们也许能够了解惰性细胞为了生存而经历的过渡,然后直接且更有效地靶向我们的治疗。

著录项

  • 作者单位

    Wayne State University.;

  • 授予单位 Wayne State University.;
  • 学科 Health Sciences Oncology.; Biology Molecular.
  • 学位 Ph.D.
  • 年度 2003
  • 页码 124 p.
  • 总页数 124
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;分子遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号